Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Debt (2016 - 2025)

Conmed's Non-Current Debt history spans 16 years, with the latest figure at $834.2 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 7.83% year-over-year to $834.2 million; the TTM value through Dec 2025 reached $834.2 million, down 7.83%, while the annual FY2025 figure was $834.2 million, 7.83% down from the prior year.
  • Non-Current Debt reached $834.2 million in Q4 2025 per CNMD's latest filing, down from $853.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.0 billion in Q3 2022 to a low of $672.4 million in Q4 2021.
  • Average Non-Current Debt over 5 years is $882.9 million, with a median of $922.6 million recorded in 2024.
  • Peak YoY movement for Non-Current Debt: decreased 10.45% in 2021, then soared 47.36% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $672.4 million in 2021, then surged by 46.5% to $985.1 million in 2022, then dropped by 1.21% to $973.1 million in 2023, then dropped by 7.0% to $905.1 million in 2024, then fell by 7.83% to $834.2 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Non-Current Debt are $834.2 million (Q4 2025), $853.0 million (Q3 2025), and $881.1 million (Q2 2025).